A Message From Our Founder

Our Commitment: Science First. Always.

At Durand Health, we believe your health decisions should be guided by evidence, not marketing.

DNA helix — science-first health intelligence

The health and wellness industry is experiencing a surge of premium screening products marketed directly to consumers and employers. From multi-cancer blood tests costing thousands of dollars to full-body MRI scans and direct-to-consumer longevity blood panels, the promise is compelling: detect disease before it starts.

We understand the appeal. Early detection saves lives. We have built our entire practice around prevention and early intervention.

But there is a critical difference between proven science and premature commercialization. And we believe Canadians deserve to know the difference.

Our Standard

What We Will Not Offer

Durand Health does not offer, promote, or recommend health screening products or tests that have not been validated by rigorous, peer-reviewed clinical evidence and endorsed by recognized professional medical societies.

The Galleri Multi-Cancer Blood Test

GRAIL's Galleri test claims to detect 50+ cancer types from a single blood draw — at over $2,000 in Canada. It is not approved by Health Canada, not approved by the FDA, and not endorsed by any professional medical society.

The largest randomized controlled trial ever conducted on multi-cancer early detection — 142,000 people across England over three years — did not meet its primary endpoint. New York Times, Feb 21, 2026: "Grail's Cancer Detection Test Fails in Major Study."

We chose science.

Full-Body MRI Screening

Full-body MRI scans are being marketed to healthy Canadians at $2,500–$5,000+, promoted by celebrity endorsements and social media influencers. No professional medical society recommends this for healthy, asymptomatic patients.

Research shows 15–30% of diagnostic imaging in adults contains at least one incidental finding — triggering unnecessary biopsies, specialist referrals, cascading costs, and significant patient anxiety.

Direct-to-Consumer "Longevity" Panels

A growing number of telehealth platforms sell "longevity" blood panels directly to consumers — 30–40 biomarkers, a "biological age" score, often without the context of a comprehensive physician-led health assessment.

A blood test without context is just a number. Testing must be part of a longitudinal health relationship, not a one-time transaction marketed as "empowerment."

Our Approach

What We Do Instead

Durand Health provides evidence-based, physician-led health intelligence.

Comprehensive Health Assessments

Proven, continuously evolving testing protocols — from advanced cardiovascular imaging and resting metabolic analysis to pharmacogenomics and metabolic health panels.

Year-Round Circle of Care

Your Durand health team works with you throughout the year — physicians, nurse practitioners, naturopaths, chiropractors, health navigators, and mental health professionals.

Testing That Is Integrated, Not Isolated

Every result is interpreted within your full clinical picture — your genetics, your lifestyle, your family history, your goals. Context is everything.

At Durand Future Health, we build a Health Intelligence Platform that is forward-looking, not rearward-looking. Physician-led. Evidence-based. Secure. Measured by outcomes, not by how many vials we can draw or how much we can charge.

Outcomes over profit. Science over speed. Patients over shareholders.

Evidence-based. Physician-led. Continuously evolving. For executives, families, and all those who expect the best.

Durand® With You for Life®

Experience Health Intelligence Done Right

Book your assessment and see the difference evidence-based care makes.